GERN (STOCKS)
Geron Corp
$1.159600
+0.009600 (+0.83%)
Prev close: $1.150000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Harout Semerjian
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $740.96M
- Employees
- 229
- P/E (TTM)
- -11.03
- P/B (TTM)
- 3.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.01 | $-0.02 | +0.0111 | +52.61% |
|
Dec 2025 (Q4)
|
$-0.02 | $-0.03 | +0.0123 | +38.08% |
|
Sep 2025 (Q3)
|
$-0.03 | $-0.03 | +0.0037 | +10.98% |
|
Jun 2025 (Q2)
|
$-0.02 | $-0.03 | +0.0111 | +35.69% |
Financial Statements
| Revenues | $196.12M |
| Benefits Costs and Expenses | $267.31M |
| Costs And Expenses | $247.84M |
| Operating Expenses | $247.84M |
| Selling, General, and Administrative Expenses | $154.66M |
| Depreciation and Amortization | $477.00K |
| Other Operating Expenses | $92.96M |
| Operating Income/Loss | -$51.72M |
| Income/Loss From Continuing Operations After Tax | -$67.31M |
| Income/Loss From Continuing Operations Before Tax | -$136.60M |
| Net Income/Loss | -$67.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$67.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$67.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.11 |
| Diluted Earnings Per Share | -$0.11 |
| Basic Average Shares | 1,334,207,568 |
| Diluted Average Shares | 1,334,207,568 |
| Assets | $534.12M |
| Current Assets | $498.53M |
| Inventory | $133.29M |
| Other Current Assets | $365.24M |
| Noncurrent Assets | $35.59M |
| Fixed Assets | $1.00M |
| Other Non-current Assets | $34.59M |
| Liabilities | $305.01M |
| Current Liabilities | $73.57M |
| Accounts Payable | $12.72M |
| Wages | $9.49M |
| Other Current Liabilities | $51.36M |
| Noncurrent Liabilities | $231.44M |
| Equity | $229.11M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $229.11M |
| Liabilities And Equity | $534.12M |
| Net Cash Flow From Operating Activities | -$125.96M |
| Net Cash Flow From Operating Activities, Continuing | -$125.96M |
| Net Cash Flow From Investing Activities | $106.66M |
| Net Cash Flow From Investing Activities, Continuing | $106.66M |
| Net Cash Flow From Financing Activities | $4.44M |
| Net Cash Flow From Financing Activities, Continuing | $4.44M |
| Exchange Gains/Losses | $33.00K |
| Net Cash Flow | -$14.83M |
| Net Cash Flow, Continuing | -$14.86M |
| Comprehensive Income/Loss | -$67.62M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.80M |
| Other Comprehensive Income/Loss | -$51.24M |